ACPA/anti-cyclic citrullinated peptides (anti-CCP, a surrogate for ACPA) (259), added to the 2010 ACR/EULAR diagnostic criteria (260), is a hallmark of RA and plays a role in disease pathogenesis (261). Here, PRTN3 is linked to rheumatoid arthritis.